Stocktoria
ACCENDRA HEALTH INC/VA/ ACH
ACCENDRA HEALTH INC/VA/ (ACH) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the distress zone. It pays a dividend yielding 0.29% (safety: no dividend). FY2025 revenue was $2.8B at a -39.8% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Wholesale Trade · percentile among 112 companies
Percentile vs other Wholesale Trade companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.163 |
| Retained earnings / assets | -0.44 |
| EBIT / assets | 0.011 |
| Equity / liabilities | -0.158 |
Sector peers · similar-size Wholesale Trade companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ACH | ACCENDRA HEALTH INC/VA/ | 3/9 | -2.59 | — | +3.1% |
| FZMD | Fuse Medical, Inc. | 4/9 | -0.25 | 0.5 | -8.7% |
| HSIC | HENRY SCHEIN INC | 4/9 | 2.71 | 24.3 | +4% |
| MCK | MCKESSON CORP | 6/9 | 0.58 | 18.8 | +12.4% |
| CAH | CARDINAL HEALTH INC | 6/9 | -0.03 | 32.5 | +14.2% |
| SYY | SYSCO CORP | 5/9 | — | 21.7 | +3.2% |
| PFGC | Performance Food Group Co | 4/9 | 1.92 | 48.3 | +7.2% |
All Wholesale Trade companies →
About ACCENDRA HEALTH INC/VA/
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
FAQ
Is ACH financially healthy?
ACCENDRA HEALTH INC/VA/'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does ACH pay a dividend, and is it safe?
Yes. ACCENDRA HEALTH INC/VA/ pays a dividend yielding about 0.29% with a None payout ratio, rated “no dividend” for safety.
How profitable is ACH?
In FY2025, ACCENDRA HEALTH INC/VA/ had a net margin of -39.8%.
Is ACH overvalued or undervalued?
ACCENDRA HEALTH INC/VA/ trades at about 4.2× trailing earnings — below its 10-year norm (10-year range 14.3×–68.1×, median 20.4×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for ACH?
The average Wall-Street price target for ACCENDRA HEALTH INC/VA/ is $4.49, about 271.1% above the recent price, from 5 analysts.
Is ACH a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on ACCENDRA HEALTH INC/VA/: a Piotroski F-score of 3/9, an Altman Z″ in the distress zone, a dividend yield of 0.29%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.